ASPEN PHAR

APNHY·04530Y106·US·ADR·Healthcare - Drug Manufacturers - Specialty & Generic

Holders

Total Value

Consensus

13F: Sep 30, 2025Insider & Congress: Updated regularly

No verdict yet — fewer than 2 funds hold APNHY.

Checking access…

	Action
RHUMBLINE ADVISERS	Exited	0(-100.0%)	$7,235	0.0%	-37.11%	0

APNHYASPEN PHAR

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

UNHUnitedHealth Group Incorporated

417 holders · $300.5B

LLYEli Lilly and Company

416 holders · $881.6B

TMOThermo Fisher Scientific Inc.

401 holders · $151.5B

JNJJohnson & Johnson

398 holders · $415.6B

DHRDanaher Corporation

395 holders · $98.9B

ISRGIntuitive Surgical, Inc.

394 holders · $111.8B

MRKMerck & Co., Inc.

391 holders · $230.3B

ABBVAbbVie, Inc.

386 holders · $303.9B

BSXBoston Scientific Corporation

386 holders · $52.4B

ABTAbbott Laboratories

383 holders · $114.2B

Questions investors ask about APNHY

Who owns APNHY?

0 institutional investors held APNHY on September 30, 2025, according to their 13F filings.

How many hedge funds hold APNHY?

0 institutional investors reported APNHY in their 13F filings for the quarter ended September 30, 2025.

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer